Virometix's Series A Round

Virometix raised a round of funding on May 22, 2017.

Virometix is a biotechnology company developing vaccines and immunotherapeutic drugs for the prevention and treatment of infectious and chronic human diseases. Rational molecular design, chemical synt…

Articles about Virometix's Series A Round: